Quality of life in patients suffering from insomnia

Innovations in Clinical Neuroscience

Volumn 9, Issue 10, 2012, Pages

  IsHak, Waguih W ^a   Bagot, Kara ^b   Thomas, Shannon ^a   Magakian, Naira ^a   Bedwani, Dina ^a   Larson, David ^c   Brownstein, Alexandra ^d   Zaky, Christine ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Insomnia; Quality of life; Sleep disorder

Indexed keywords

BENZODIAZEPINE DERIVATIVE; BENZODIAZEPINE RECEPTOR STIMULATING AGENT; CARBAMAZEPINE; CHLORPROMAZINE; ESZOPICLONE; FLUOXETINE; HORMONE RECEPTOR STIMULATING AGENT; LAMOTRIGINE; MELATONIN; MELATONIN DERIVATIVE; MELATONIN RECEPTOR AGONIST; MIRTAZAPINE; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; PLACEBO; QUETIAPINE; SEROTONIN UPTAKE INHIBITOR; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; VALPROIC ACID; ZOPLICONE;

ANXIETY DISORDER; BECK DEPRESSION INVENTORY; BEHAVIOR THERAPY; CHILD ABUSE; COGNITIVE THERAPY; COMORBIDITY; CONGESTIVE HEART FAILURE; DEPRESSION; DRUG EFFICACY; DRUG SAFETY; EMOTION; GENERALIZED ANXIETY DISORDER; HAMILTON SCALE; HEALTH CARE COST; HUMAN; INSOMNIA; INTENSIVE CARE UNIT; JOB PERFORMANCE; MALIGNANT NEOPLASTIC DISEASE; MENTAL HEALTH; NARCOLEPSY; NEUROLOGIC DISEASE; PHYSICAL CAPACITY; POSTTRAUMATIC STRESS DISORDER; QUALITY OF LIFE; RESTLESS LEGS SYNDROME; REVIEW; SELF REPORT; SLEEP DISORDER; SLEEP DISORDERED BREATHING; SLEEP QUALITY; SNORING; SOCIAL ASPECT; SYSTEMATIC REVIEW; TRAUMATIC BRAIN INJURY; WELLBEING;

EID: 84869385705     PISSN: 21588333     EISSN: 21588341     Source Type: Journal    
DOI: None     Document Type: Review

References (83)

1. The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med. 1995;41:1403-1409.
2. Wade AG. The societal costs of insomnia. Neuropsychiatr Dis Treat. 2010;7:1-18.
3. Kyle SD, Morgan K, Espie CA. Insomnia and health related quality of life. Sleep Med Rev. 2010;14:69-82.
4. Léger D, Bayon V. Societal costs of insomnia. Sleep Med Rev. 2010;14:379-389.
5. Buysse DJ, Angst J, Gamma A, et al. Prevalence, course, and comorbidity of insomnia and depression in young adults. Sleep. 2008;31:473-480.
6. Morin CM, LeBlanc M, Daley M, et al. Epidemiology of insomnia: prevalence, self-help treatments, consultations, and determinants of help-seeking behaviors. Sleep Med. 2006;7:123-130.
7. Mai E, Buysse DJ. Insomnia: prevalence, impact, pathogenesis, differential diagnosis, and evaluation. Sleep Med Clin. 2008;3:167-174.
8. Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev. 2002;6:97-111.
9. Insomnia, an international consensus conference report-Versailles, 13-15 October. Worldwide Project on Sleep and Health. Geneva: Division of Mental Health and Prevention of Substance Abuse, World Health Organization; 1998.
10. Walsh JK, Krystal AD, Amato DA, et al. Nightly treatment of primary insomnia with eszopiclone for 6 months: effect on sleep, quality of life, and work limitations. Sleep. 2007;30:959-968.
11. Zammit GK, Weiner J, Damato N, et al. Quality of life in people with insomnia. Sleep. 1999;22:S379-S385.
12. Schubert CR, Cruickshanks KJ, Dalton DS, et al. Prevalence of sleep problems and quality of life in an older population. Sleep. 2002;25:889-893.
13. Stein MB, Belik SL, Jacobi F, Sareen J. Impairment associated with sleep problems in the community, relationship to physical and mental co-morbidity. Psychosom Med. 2008;70:913-919.
14. Berger AM, Kuhn BR, Farr LA, et al. Behavioral therapy intervention trial to improve sleep quality and cancer-related fatigue. Psycho-Oncology. 2009;18:634-646.
15. Lis CG, Gupta D, Grutsch JF. The relationship between insomnia and patient satisfaction with quality of life in cancer. Support Care Cancer. 2008;16:261-2666.
16. Byles JE, Mishra GD, Harris MA, Nair K. The problems of sleep for older women: changes in health outcomes. Age Ageing. 2003;32:154-163.
17. Léger D, Scheuermaier K, Philip P, et al. SF-36: evaluation of quality of life in severe and mild insomniacs compared with good sleepers. Psychosom Med. 2001;63:49-55.
18. Reimer MA, Flemons WW. Quality of life in sleep disorders. Sleep Med Rev. 2001;7:335-349.
19. Léger D, Scheuermaier K, Raffray T, et al. HD-16: a new quality of life instrument specifically designed for insomnia. Sleep Med. 2005;6:191-198.
20. Endicott J, Nee J, Harrison W, et al. Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacol Bull. 1993;29:321-326.
21. Schechter D, Endicott J, Nee J. Quality of life of 'normal' controls: association with lifetime history of mental illness. Psychiatry Res. 2007;152:45-54.
22. McCall WV, Blocker JN, D'Agostino R, et al. Treatment of insomnia in depressed insomniacs: effects of health-related quality of life, objective and self-reported sleep, and depression. J Clin Sleep Med. 2010;6:322-329.
23. Skevington SM, Lotfy M, O'Connell KA. The World Health Organization's WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHO-QOL group. Qual Life Res. 2004;13:299-310.
24. Mathews WC, May S. EuroQol (EQ-5D) measure of quality of life predicts mortality, emergency department utilization, and hospital discharge rates. Health Qual Life Outcomes. 2007;5:5.
25. IsHak WW, Greenberg JM, Balayan K, et al. Quality of life: the ultimate outcome measure of interventions in major depressive disorder. Harv Rev Psychiatry. 2011;19:229-239.
26. Rombaut N, Maillard F, Kelly F, Hindmarch I. The quality of life of insomniacs questionnaire (QOLI). Med Sci Res. 1990;18:845-47.
27. Philip P, Léger D, Quera-Salva MA, et al. Insomniac complaints interfere with quality of life but not absenteeism: respective role of depressive and organic comorbidity. Sleep Med. 2006;7:585-591.
28. Eisen SV, Dill DL, Grob MC. Reliability and validity of a brief patient-report instrument for psychiatric outcome evaluation. Hosp Community Psychiatry. 1994;45:242-247.
29. Katz DA, McHorney CA. The relationship between insomnia and health related quality of life in patients with chronic illness. J Fam Pract. 2002;51:229-235.
30. Roth T, Drake C. Evolution of insomnia:current status and future direction. Sleep Med. 2004;5(Suppl 1):S23-S30.
31. Stein MB, Barret-Conner E. Quality of life in older adults receiving medications for anxiety, depression or insomnia. Am J Geriatr Psychiatry. 2002;5:568-574.
32. Hatoum HT, Kong SX, Kania CM, et al. Insomnia, health related quality of life and health care resource consumption. Pharmacoeconomics. 1998;14:629-637.
33. Léger D, Guilleminault C, Bader G, et al. Medical and socio-professional impact of insomnia. Sleep. 2002;25:625-629.
34. Gureje O, Kola L, Ademola A, Olley BO. Profile comorbidity and impact of insomnia in the Ibadan study of ageing. Int J Geriatr Psychiatry. 2009;24:686-693.
35. Lee M, Choh AC, Demerath EW, et al. Sleep disturbance in relation to Health-related quality of life in adults. J Nutr Health Aging. 2009;13:576-583.
36. Dikeos DG, Soldatos CR. The condition of insomnia: etiopathogenetic considerations and their impact on treatment practices. Int Rev Psychiatry. 2005;17:255-262.
37. Vallieres A, Ivers H, Bastien CH, et al. Variability and predictability in sleep patterns of chronic insomniacs. J Sleep Res. 2005;14:447-453.
38. Smith MT, Perlis ML, Park A, et al. Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia. Am J Psychiatry. 2002;150:5-11.
39. Breslau N, Roth T, Rosenthal L, et al. Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults. Biol Psychiatry. 1996;39:411-418.
40. Sunderajan P, Gaynes BN, Wisniewski SR, et al. Insomnia in patients with depression: a STAR*D report. CNS Spectr. 2010;15:394-404.
41. Nierenburg AA, Keefe BR, Leslie VC, et al. Residual symptoms in depressed patients who respond acutely to fluoxetine. J Clin Psychiatry. 1999;60:221-225.
42. Mahendran R, Subramaniam M, Chan YH. Psychiatric morbidity in patients referred to an insomnia clinic. Singapore Med J. 2007;48:163-165.
43. Brenes GA, Miller ME, Stanley MA, et al. Insomnia in older adults with generalized anxiety disorder. Am J Geriatr Psychiatry. 2009;17:465-472.
44. Kim K, Uchiyama M, Liu X, et al. Somatic and psychological complaints and their correlates with insomnia in the Japanese general population. Psychosom Med. 2001;6:441-446.
45. Léger D, Stal V, Guilleminault C, et al. Diurnal consequences of insomnia; impact on quality of life. Rev Neurol (Paris). 2001;1571270-1278.
46. Lew HL, Vanderploeg RD, Morre DF, et al. Overlap of mild TBI and mental health conditions in returning OIF/OEF service members and veterans. J Rehabil Res Dev. 2008;45:6-11.
47. Pittman J, Goldsmith AA, Lemmer JA, et al. Post-traumatic stress disorder, depression and health-related quality of life in OEF/OIF veterans. Qual Life Res. 2012;21:99-103.
48. McLay RN, Klam WP, Volkert SL. Insomnia is the most commonly reported symptom and predicts other symptoms of post-traumatic stress disorder in U.S. service members returning from military deployments. Mil Med. 2010;175:759-762.
49. Wallace DM, Shafazand S, Ramos AR, et al. Insomnia characteristics and clinical correlates in Operation Enduring Freedom/Operation Iraqi Freedom veterans with post-traumatic stress disorder and mild traumatic brain injury: an exploratory study. Sleep Med. 2011;12:850-859.
50. Poon, CY, Knight BG. Impact of childhood parental abuse and neglect on sleep problems in old age. J Gerontol B Psychol Sci Soc Sci. 2011;66:307-310.
51. Ozminkowski RJ, Wang S, Walsh JK. The direct and indirect costs of untreated insomnia in adults in the United States. Sleep. 2007;30:263-273.
52. Hatoum HT, Kong SX, Kania CM, et al. Insomnia, health-related quality of life and healthcare resource consumption: a study of managed care organizations enrollees. Pharmacoeconomics. 1998;14:629-637.
53. Rosekind MR, Gregory KB. Insomnia risks and costs:health, safety, and quality of life. Am J Manag Care. 2010;16:617-626.
54. Estivill E, Bov A, Garca-Borreguero D, et al. Consensus on drug treatment, definition and diagnosis for insomnia. Clin Drug Invest. 2003;23:351-385.
55. Cheng KK, Lee DTF. Effects of pain, insomnia, and mood disturbance on functional status and quality of life of elderly patients with cancer. Crit Rev Oncol Hematol. 2011;78:127-137.
56. O'Donnel JF. Insomnia in cancer patients. Clin Cornerstone. 2004;6:S6-S14.
57. Lew HL, Pogoda TK, Hsu PT, et al. Impact of the "polytrauma clinical triad" on sleep disturbance in a department of veteran affairs outpatient rehabilitation setting. Am J Phys Med Rehabil. 2010;89:437-445.
58. Ouellet MC, Beaulieu-Bonneau S, Morin CM. Insomnia in patients with traumatic brain injury: frequency, characteristics, and risk factors. J Head Trauma Rehabil. 2006;21:199-212.
59. Dauvilliers Y. Insomnia in patients with neurodegenerative conditions. Sleep Med. 2007;8:S27-S34.
60. Caap-Ahlgren M, Devlin O. Insomnia and depressive symptoms in patients with Parkinson's disease-relationship to health-related quality of life. An interview study of patients living at home. Arch Gerontol Geriatr. 2001;32:23-33.
61. BaHammam A. Sleep in acute care units. Sleep Breath. 2006;10:6-15.
62. Granja C, Lopes A, Moreira S, et al. Patients' recollections of experiences in the intensive care unit may affect their quality of life. Crit Care. 2005;9:R96-R109.
63. Lee CM, Herridge MS, Gabor JY, et al. Chronic sleep disorders in survivors of the acute respiratory distress syndrome. Intensive Care Med. 2009;35:314-320.
64. Krakow B, Melendrez D, Sisley B, et al. Nasal dilator strip therapy for chronic sleep maintenance insomnia and symptoms of sleep disordered breathing. Sleep Breath. 2006;10:16-28.
65. Johansson P, Arestedt K, Alehagen U, et al. Sleep disordered breathing, insomnia, and health related quality of life: a comparison between age and gender matched elderly with heart failure or without cardiovascular disease. Eur J Cardiocasc Nurs. 2010;9:108-117.
66. Bjornsdottir E, Janson C, Gislason T, et al. Insomnia in untreated sleep apnea patients compared to controls. J Sleep Res. 2011;21:131-138.
67. Goldenberg F, Hindmarch I, Joyce CB, et al. Zopiclone, sleep and health-related quality of life. Human Psychopharmacol Clin Exper. 1994;9:245-251.
68. Morin AK. Strategies for treating chronic insomnia. Am J Manag Care. 2006;12suppl:S230-S245.
69. Walsh JK, Krystal AD, Amtao DA, et al. Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations. Sleep. 2007;30:959-968.
70. Scharf M, Erman M, Rosenberg R, et al. A 2-week efficacy and safety study of eszopiclone in elderly patients with primary insomnia. Sleep. 2005;28:720-727.
71. Turek FW, Gillette MU. Melatonin, sleep, and circadian rhythms: rationale for development of specific melatonin agonists. Sleep Med. 2004;5:523-532.
72. Taylor SR, Weiss JS. Review of insomnia pharmacotherapy options for the elderly: implications for managed care. Popul Health Manag. 2009;12:317-323.
73. Sasai T, Inoue Y, Komada Y, et al. Effects of insomnia and sleep medication on health-related quality of life. Sleep Med. 2010;11:452-457.
74. Dixon S, Morgan K, Mathers N, et al. Impact of cognitive behavior therapy on health-related quality of life adult hypnotic users with chronic insomnia. Behav Sleep Med. 2006;4:71-82.
75. Morgan K, Dixon S, Mathers N, et al. Psychological treatment for insomnia in the management of long term hypnotic drug use. Br J Gen Pract. 2003;53:923-928.
76. Roth T, Drake C. Evolution of insomnia:current status and future direction. Sleep Med. 2004;5(Suppl 1):S23-S30.
77. Van Houdenhove l, Buyse B, Gabriels L, Van den Bergh O. Treating primary insomnia: clinical effectiveness and predictors of outcomes on sleep, daytime function and health-related quality of life. J Clin Psychol Med Settings. 2011;18:312-321.
78. Espie CA. ABC of sleep disorders. Practical management of insomnia: behavioral and cognitive techniques. BMJ. 1993;306:509-511.
79. Espie CA, Fleming L, Cassidy J, et al. Randomized controlled clinical effectiveness trial of cognitive behavior therapy compared with treatment as usual for persistent insomnia in patients with cancer. J Clin Oncol. 2008;28:4651-4658.
80. Soeffing JP, Lichstein KL, Nau SD, et al. Psychological treatment of insomnia in hypnotic-dependent older adults. Sleep Med. 2008;9:165-171.
81. Léger D, Janus C, Pellois A, et al. Sleep, morning alertness and quality of life in subjects treated with zoplicone and in good sleepers. Study comparing 167 patients and 381 good sleepers. Eur Psychiatry. 1995;10:99S-102S.
82. Hajak G, Cluydts R, Declerck A, et al. Continuous versus non-nightly use of zolpidem in chronic insomnia:results of a large-scale, double-blind, randomized, outpatient study. Int Clin Psychopharmacol. 2002;17:9-17.
83. Verbeek IH, Konings GM, Aldenkamp AP, et al. Cognitive behavioral treatment in clinically referred chronic insomniacs: group versus individual treatment. Behav Sleep Med. 2006;4:135-151.